The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could actually support. That gap created a backlash the legitimate medical thesis didn't deserve. What's left on the other side of the green rush is a near-complete forgetting of the reason this industry started in the first place. The medicine. Now the infrastructure to prove it is finally in place. Standardized genetics. Reproducible extraction. Full compound characterization. An FDA botanical drug pathway that has existed since 2016 that most investors have never heard of. Organic medicine versus synthetic single-molecule will be a real choice at the pharmacy counter sooner than most people expect. The foundational work is already here. This week we sit down with Joel Stanley and Dr. Marcel Bonn-Miller: Botanical drugs vs. supplements 6,000 compounds, one drug Novel compounds nobody has named yet
The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention.
CBD is not a panacea. When Charlotte's Web opened hearts and minds, the messaging of what it could do ran years ahead of what the data could actually support. That gap created a backlash the legitimate medical thesis didn't deserve. What's left on the other side of the green rush is a near-complete forgetting of the reason this industry started in the first place. The medicine. Now the infrastructure to prove it is finally in place. Standardized genetics. Reproducible extraction. Full compound characterization. An FDA botanical drug pathway that has existed since 2016 that most investors have never heard of. Organic medicine versus synthetic single-molecule will be a real choice at the pharmacy counter sooner than most people expect. The foundational work is already here.
This week we sit down with Joel Stanley and Dr. Marcel Bonn-Miller:
Chapters
00:00 Why Medical Validation Remains a Challenge for Cannabis
00:12 The FDA Approval Process for Plant-Based Medicines
01:03 Historical Market Dynamics and Their Impact on Cannabis Perception
02:48 Removing the Veil: How Science Can Validate Cannabinoid Therapies
03:15 The Complexity of Plant Molecules and Real-World Evidence
06:20 Focus in Drug Development: The Case of Autism Spectrum Disorder
07:10 The Impact of Charlotte's Web and Media Hype
08:52 Balancing Hype and Reality in Cannabinoid Medicine
10:01 Legitimization of Cannabis Research in Academia
12:10 The Evolution of Cannabis Research and Acceptance
13:54 The Future of Botanical Medicine and Academic Research
16:15 The Long Road of Drug Development for Cannabis-Based Medicines
20:50 Introducing AJA-001: A Botanical Drug for Autism
22:44 Standardization and Characterization of Botanical Drugs
24:01 Partnerships and Funding in Botanical Drug Development
24:40 Challenges of Multi-Compound Botanical Drugs
27:28 Reproducibility and Quality Control in Botanical Manufacturing
29:06 FDA Pathways for Botanical Drugs and New Chemical Entities
34:29 Identifying and Characterizing Thousands of Plant Compounds
39:48 The Role of AI and Supercomputing in Drug Discovery
41:11 Balancing Exploration and Focus in Botanical Research
44:38 What the World Will Understand About Cannabinoids in 10 Years
47:24 The Promise of Botanical Medicine Over Single Molecule Drugs
Guest Links:
AJNA Biosciences Website
https://ajnabiosciences.com/
AJNA Biosciences LinkedIn
https://www.linkedin.com/company/ajna-biosciences/posts/?feedView=all
AJNA Biosciences Instagram
@ajnabiosciences
Charlotte’s Web Website
https://www.charlottesweb.com/
Charlotte’s Web LinkedIn
https://www.linkedin.com/company/charlottesweb/posts/?feedView=all
Charlotte’s Web Instagram
@charlotteswebcbd
Joel Stanley LinkedIn
https://www.linkedin.com/in/joel-stanley-2885116b/
Joel Stanley Instagram
@joel.stanley
Dr. Marcel Bonn-Miller LinkedIn
https://www.linkedin.com/in/marcel-bonn-miller-897a581/
Our Links:
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared global podcast
The Dime is a top 10 Cannabis Podcast
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube: The Dime
📸 Instagram: The Dime